Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins

(Bloomberg) -- Pfizer Inc. topped analysts’ earnings estimates after boosting the prices for several key drugs including blood thinner Eliquis, arthritis drug Xeljanz and cancer treatment Ibrance.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.